VirusIQ selects the WISeKey Digital
Health Passport for COVID-19 to secure digital health screening,
telemedicine and diagnostic services
Geneva – September 24, 2020 – WISeKey International Holding
(“WISeKey”, SIX: WIHN, NASDAQ: WKEY), a leading cybersecurity and
IoT company, signed a Strategic Collaboration Agreement with ClinIQ
Inc, a healthcare incubator platform, to secure digital health
screening, telemedicine and diagnostic services. ClinIQ
Inc has worked with Oxford University Innovation to launch VirusIQ
is a screening platform that specialises in early detection,
prevention and management of virus diseases such as COVID-19. The
screening platform provides private, secure and safe identity
management, digital health screening, telemedicine and diagnostic
services.
The collaboration with ClinIQ reinforces WISeKey’s main
objective of establishing a foothold into this new segment which is
projected to bring over $2 million in revenue for the Company in
calendar year 2021 while at the same time it creates significant
new market opportunities in the healthcare sector.
WIShelter SafePass will leverage a suite of cutting-edge eHealth
secure services combining WISeID and VirusIQ platforms to ensure
users’ privacy, security and safety whilst providing access to
diagnostics, vaccine education and necessary medical services and
data.
WISeID is a trusted identity service that enables access to the
web and mobile applications with strong authentication techniques.
WISeID supports online KYC onboarding, OTP and digital certificate
login, and an innovative “hands-free” secure login based on
QR-Codes which users can read using WIShelter SafePass mobile
application without even having to type any password. Additional
security services include digital signature services for documents.
WISeID implements standards such as OpenID Connect and OAUTH2, that
can be easily integrated by customers to enhance the security of
their cloud applications. WISeID can also be combined with
Microsoft Active Directory, facilitating integration with corporate
applications.
WISeKey, powered by VirusIQ, delivers a unique platform to
governments, institutions, individuals, and transportation, sports,
and entertainment companies that allows the early diagnosis and
management of COVID-19 or other pandemic outbreaks. This mobile
platform provides rapid access to digital health screening and
individual’s medical information, including COVID-19 testing and
vaccination reports, digitally signed by accredited bodies, as
evidence of certified immunity status. These tools will enable
businesses restricted by COVID-19 to quickly reopen and
rebuild.
The WIShelter Safepass suite was built by leaders in the
clinical and technical field and allows for scalability and
flexibility. It enables users to identify clinical COVID
biomarkers, contact tracing, diagnostics, and triage for vaccine
access, whilst keeping security at its core.
"The collaboration between VirusIQ and WiseKey is a testament to
our common mission in keeping all citizens safe and enabling secure
access to healthcare resources. Our collaboration is an important
next step in bringing the world a digital health product that can
be trusted to safeguard an individual's health and identity data.
We believe in improving private, secure, and safe mHealth
technology that endears confidence in government, business, and
community stakeholders. The future is brighter when we can work
together to safely address healthcare needs," said Dr. Ajintha
Pathmanathan, CEO of ClinIQ Inc and VirusIQ Ltd.
"We are proud of this strategic collaboration agreement with
VirusIQ which strengthens and accelerates our strategy in the
sector, by bringing technological components that meet the
requirements of securing medical profiles and data while completing
a coherent value proposition within the framework of a digital
transformation required by the industry suffering the effects of
the Covid-19 pandemic. This agreement continues the line of recent
collaborations WISeKey established with Digid Diagonostics
and arago," indicated Carlos Moreno, Vice-President of WISeKey
Corporate Alliances and Partnerships.
About VirusIQ VirusIQ is a product and
subsidiary of ClinIQ Inc (a healthcare incubator platform). VirusIQ
Ltd was formed in January 2020 in response to the SARS-COV-2
outbreak in China with the purpose of early detection and
prevention of viral outbreaks. The founder, Dr Ajintha
Pathmanathan, an Anaesthesiologist and Public Health doctor with
experience in treating patients during SARS-COV-1 predicted as
early as January 2020 an impending pandemic with the available data
and immediately commenced building a team and the
platform.
The VirusIQ team believes in global collaboration to ensure the
deployment of private, secure and safe tools to help early detect,
prevent outbreaks, improve healthcare access and reopen the
community.
Press and Investor Contact:Jenna Morgenstern-GainesClinIQ
Incpublic_affairs@cliniq.health
About WISeKey:WISeKey (NASDAQ: WKEY; SIX Swiss
Exchange: WIHN) is a leading global cybersecurity company currently
deploying large scale digital identity ecosystems for people and
objects using Blockchain, AI and IoT respecting the Human as the
Fulcrum of the Internet. WISeKey microprocessors secure the
pervasive computing shaping today’s Internet of Everything. WISeKey
IoT has an installed base of over 1.5 billion microchips in
virtually all IoT sectors (connected cars, smart cities, drones,
agricultural sensors, anti-counterfeiting, smart lighting, servers,
computers, mobile phones, crypto tokens etc.). WISeKey is
uniquely positioned to be at the edge of IoT as our semiconductors
produce a huge amount of Big Data that, when analyzed with
Artificial Intelligence (AI), can help industrial applications to
predict the failure of their equipment before it happens.
Our technology is Trusted by the OISTE/WISeKey’s Swiss based
cryptographic Root of Trust (“RoT”) provides secure authentication
and identification, in both physical and virtual environments, for
the Internet of Things, Blockchain and Artificial Intelligence. The
WISeKey RoT serves as a common trust anchor to ensure the integrity
of online transactions among objects and between objects and
people. For more information, visit www.wisekey.com.
Press and investor contacts:
WISeKey SA Company Contact: Carlos MoreiraChairman
& CEOTel: +41 22 594
3000info@wisekey.com WISeKey Investor
Relations (US) Contact: Lena CatiThe Equity Group
Inc.Tel: +1 212 836-9611lcati@equityny.com
Disclaimer:This communication expressly or implicitly contains
certain forward-looking statements concerning WISeKey International
Holding Ltd and its business. Such statements involve certain known
and unknown risks, uncertainties and other factors, which could
cause the actual results, financial condition, performance or
achievements of WISeKey International Holding Ltd to be materially
different from any future results, performance or achievements
expressed or implied by such forward-looking statements. WISeKey
International Holding Ltd is providing this communication as of
this date and does not undertake to update any forward-looking
statements contained herein as a result of new information, future
events or otherwise.
This press release does not constitute an offer to sell, or a
solicitation of an offer to buy, any securities, and it does not
constitute an offering prospectus within the meaning of the Swiss
Financial Services Act (“FinSA”), the FInSa’s predecessor
legislation or advertising within the meaning of the FinSA,
or within the meaning of any other securities regulation. Investors
must rely on their own evaluation of WISeKey and its securities,
including the merits and risks involved. Nothing contained herein
is, or shall be relied on as, a promise or representation as to the
future performance of WISeKey.
The securities offered will not be, and have not been,
registered under the United States of America Securities Act of
1933, as amended, and may not be offered or sold in the United
States of America, absent registration or an applicable exemption
from the registration requirements of said Act.
WISeKey (NASDAQ:WKEY)
Historical Stock Chart
From Mar 2024 to Apr 2024
WISeKey (NASDAQ:WKEY)
Historical Stock Chart
From Apr 2023 to Apr 2024